Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Recombinant
100%
Natural Killer Cells
100%
Cancer Cells
100%
High Affinity
100%
IgG Receptors
100%
Therapeutic mAb
100%
CD64
60%
CD16a
50%
Fc Receptor
30%
Antibody-dependent Cellular Cytotoxicity
30%
ADAM17
20%
Antitumor
20%
NK Cell Activity
20%
Cancer Patients
10%
Leukocytes
10%
Malignancy
10%
Tumor
10%
Induced Pluripotent Stem Cells (iPSCs)
10%
Tumor Cells
10%
Cell Therapy
10%
Tumor Targeting
10%
Cancer Immunotherapy
10%
Mechanism of Action
10%
Two-component
10%
Effector Function
10%
Cell-mediated
10%
Tumor Cell Death
10%
Low Affinity
10%
Targeted Therapeutics
10%
Functional Activity
10%
Conjugation
10%
IgG Antibody
10%
Extracellular Region
10%
NK-92
10%
Activating Receptors
10%
NK Cell Lines
10%
Cytokine Production
10%
Cytoplasmic Area
10%
Chimeric Protein
10%
Regulatory Process
10%
Transmembrane Region
10%
IgG Fc
10%
Proteolytic Cascade
10%
Tumor Environment
10%
Novel Recombinants
10%
Cell Binding
10%
Therapeutic IgG
10%
Immunology and Microbiology
Natural Killer Cell
100%
Cancer Cell
100%
Fc Receptor
100%
Antibody-Dependent Cell-Mediated Cytotoxicity
25%
ADAM17
16%
Cell Activation
16%
Tumor Cell
16%
Cell Line
8%
Cell Killing
8%
Leukocyte
8%
down Regulation
8%
Induced Pluripotent Stem Cell
8%
Immunoglobulin G
8%
Cytokine Production
8%
Cell Antibody
8%
Cancer Immunotherapy
8%